Grant proposals will be reviewed biannually, and should be submitted according to the following timeline:
Application Deadline:
March 15
September 15Decision Made By:
April 30
October 31
Proposals are reviewed and recommendations made to fund or decline by the Scientific Review Committee. They are then reviewed and a final decision to approve or decline made by the Board of Trustees. In reviewing a proposal, the Proposal Evaluation Criteria will be used as a guideline to determine the study's fundability.
Be sure to include all required documentation, including a detailed budget for the project. Incomplete applications will delay the approval process.
If the board approves funding, a formal Letter of Agreement (LOA) between the ResMed Foundation and grantee will be sent for signature. Upon receipt of two fully executed originals, the initial funding payment will be made. Subsequent payments will be made based on the progress of the study, as outlined in the Semi-Annual Reports. The Foundation reserves the right to discontinue funding if the study is not carried out in a timely manner, patient recruitments achieved and/or the study in compliance with the original grant proposal.
June 15
December 15
Kristi Burlingame
Executive Director
ResMed Foundation
7514 Girard Avenue
Suite I-343
La Jolla, CA 92037
e: kristib@resmedfoundation.org
t: 858-361-0755
Applications may be submitted via the web: Apply Online.
Grant proposals will be reviewed biannually, and should be submitted according to the following timeline:
Application Deadline:
March 15
September 15Decision Made By:
April 30
October 31
Proposals are reviewed and recommendations made to fund or decline by the Scientific Review Committee. They are then reviewed and a final decision to approve or decline made by the Board of Trustees. In reviewing a proposal, the Proposal Evaluation Criteria will be used as a guideline to determine the study's fundability.
Be sure to include all required documentation, including a detailed budget for the project. Incomplete applications will delay the approval process.
If the board approves funding, a formal Letter of Agreement (LOA) between the ResMed Foundation and grantee will be sent for signature. Upon receipt of two fully executed originals, the initial funding payment will be made. Subsequent payments will be made based on the progress of the study, as outlined in the Semi-Annual Reports. The Foundation reserves the right to discontinue funding if the study is not carried out in a timely manner, patient recruitments achieved and/or the study in compliance with the original grant proposal.
June 15
December 15
Kristi Burlingame
Executive Director
ResMed Foundation
7514 Girard Avenue
Suite I-343
La Jolla, CA 92037
e: kristib@resmedfoundation.org
t: 858-361-0755
Applications may be submitted via the web: Apply Online.